Provided By GlobeNewswire
Last update: Feb 1, 2024
Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets
Complementary Capabilities Range from API Manufacturing through Process Development and cGMP Manufacturing to Fill/Finish
Read more at globenewswire.com